Description
Product Description
Compound Fetal Liver Iron Ammonium Tablets consist of iron salts derived from ammonium-ferric complexes and enriched fetal liver extracts. The formulation is optimized for bioavailability and stability, allowing for consistent delivery of iron in laboratory models.
The tablets provide a controlled source of elemental iron and other trace nutrients that are critical for erythropoiesis, hemoglobin synthesis, and red blood cell maturation. They are widely used in preclinical studies, including:
Models of iron-deficiency anemia;
Investigations of iron transport and absorption mechanisms;
Evaluation of erythropoietic factors and regulatory pathways;
Studies on oxidative stress associated with iron metabolism;
Nutritional and metabolic research related to iron homeostasis.
By using standardized tablets, researchers can ensure reproducibility across experimental cohorts and reduce variability in iron supplementation studies. These tablets are particularly valuable in mechanistic studies of iron-related disorders, testing therapeutic interventions, and analyzing hematological parameters.
Product Specifications
| Item | Details |
|---|---|
| Product Name | Compound Fetal Liver Iron Ammonium Tablets |
| Active Ingredient | Iron (Fe) in ammonium-ferric complex |
| Source | Fetal liver extract and synthetic iron salts |
| Molecular Formula | Variable (mixture of iron compounds and amino acids) |
| Purity | ≥99% elemental iron equivalence |
| Appearance | Brownish tablet, uniform in size and weight |
| Solubility | Insoluble in water; dissolves in acidic medium |
| Storage Temperature | 2–25°C, dry and protected from light |
| Category | Iron supplement for research |
| Applications | Iron metabolism studies, anemia models, hematopoiesis research, oxidative stress assays |
| Formulation | Oral tablet for in vitro or animal studies |
| Stability | Stable under recommended storage conditions for 24 months |
| Shelf Life | 24 months |
| Supplier Type | Laboratory research chemical supplier |
| Intended Use | For laboratory and preclinical research only |
Mechanism of Action
Compound Fetal Liver Iron Ammonium Tablets provide bioavailable iron essential for hemoglobin synthesis, myoglobin formation, and cellular iron-dependent enzymatic processes.
1. Iron Absorption and Transport
Iron from these tablets is absorbed in the duodenum and jejunum through divalent metal transporter 1 (DMT1) and ferric reductase pathways. Once in circulation, iron binds to transferrin for systemic distribution to erythroid precursors and other iron-requiring tissues.
2. Erythropoiesis and Hemoglobin Synthesis
Supplemental iron supports red blood cell production by promoting heme synthesis in developing erythroblasts. This leads to increased hemoglobin concentration and improved oxygen-carrying capacity in experimental animal models.
3. Enzymatic and Metabolic Role
Iron acts as a cofactor in enzymes such as ribonucleotide reductase, cytochromes, and catalases, regulating DNA synthesis, oxidative metabolism, and cellular antioxidant defense. The tablets help maintain iron homeostasis in laboratory models.
4. Oxidative Stress and Iron Regulation
Iron supplementation must be carefully controlled to prevent free radical generation. Compound Fetal Liver Iron Ammonium Tablets provide a balanced iron source that minimizes pro-oxidant effects while maintaining physiological iron levels for research purposes.
5. Preclinical and Mechanistic Research Applications
Researchers use these tablets to simulate iron-deficiency and iron-repletion states in vitro and in vivo, study iron-responsive gene expression, test novel iron chelators, or evaluate nutritional interventions in animal models.

Side Effects
Compound Fetal Liver Iron Ammonium Tablets are intended strictly for laboratory and preclinical research. Considerations include:
Iron overload in sensitive models if doses exceed experimental requirements;
Potential oxidative stress at supra-physiological iron concentrations;
Gastrointestinal discomfort in animal models when administered orally;
Need for precise dosing and adherence to ethical research protocols.
These tablets are not intended for human consumption and should be handled under laboratory safety guidelines.
Keywords
Compound Fetal Liver Iron Ammonium Tablets, iron supplement, iron metabolism, anemia model, erythropoiesis research, hematology research, preclinical iron studies, high-purity iron tablets
Shipping Guarantee
All Compound Fetal Liver Iron Ammonium shipments are handled using validated logistics to preserve tablet integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping. Products are shipped via express international couriers with full tracking and insurance coverage.
Trade Assurance
We Compound Fetal Liver Iron Ammonium ensure product authenticity, verified ≥99% elemental iron equivalence, and compliance with analytical standards. Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.
Payment Support
We Compound Fetal Liver Iron Ammonium provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.
Disclaimer
All Compound Fetal Liver Iron Ammonium products listed are intended for laboratory and preclinical research use only and not for human or veterinary use. They are not drugs, medical devices, or diagnostics and should not be administered to humans or animals. Researchers must handle all materials in accordance with institutional biosafety and chemical safety guidelines. The information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.


Reviews
There are no reviews yet.